Evidence map›Paper›PMID 24231659›Full record

ArticleJournal of the American Society of Nephrology : JASN2014

Protein phosphatase 1 inhibitor-1 deficiency reduces phosphorylation of renal NaCl cotransporter and causes arterial hypotension.

Nicolas Picard, Katja Trompf, Chao-Ling Yang, R Lance Miller, Monique Carrel, Dominique Loffing-Cueni, Robert A Fenton, David H Ellison, Johannes Loffing

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. ET-3/ETBR Mediates NaCirculation research · 2025
    Article
  6. Review
  7. Acute kidney injury results in long-term alterations of kidney lymphatics in mice.American journal of physiology. Renal physiology · 2024
    Article
  8. Review
  9. Arginine vasopressin regulates the renal NaAmerican journal of physiology. Renal physiology · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Potassium homeostasis: sensors, mediators, and targets.Pflugers Archiv : European journal of physiology · 2022
    Review
  15. Renal calcium and magnesium handling in Gitelman syndrome.American journal of translational research · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Roles of WNK4 and SPAK in KAmerican journal of physiology. Renal physiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Nicolas PicardInstitute of Anatomy, University of Zurich, Zurich, Switzerland;
Katja Trompf
Chao-Ling Yang
R Lance Miller
Monique Carrel
Dominique Loffing-Cueni
Robert A Fenton
David H Ellison
Johannes Loffing
University of Zurich · CHOregon Health & Science University · USAarhus University · DKInserm · FRNational Institutes of Health · US

Funding

WNK Kinase Regulation of Thiazide-sensitive NaCl TransportR01DK051496 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI David Hoadley Ellison, CHAO-LING YANG · 1998 to 2026
$8.4M
Molecular pathogenesis of calcineurin inhibitor-induced hypertensionR01DK095841 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLISON, DAVID H, YANG, CHAO-LING · 2012 to 2015
$1.5M
NIDDK NIH HHS R01 1RO1 DK095841NIDDK NIH HHS R01 DK051496NIDDK NIH HHS R01 DK095841NIDDK NIH HHS R01 DK51496
6 · The paper itself

Abstract

The thiazide-sensitive NaCl cotransporter (NCC) of the renal distal convoluted tubule (DCT) controls ion homeostasis and arterial BP. Loss-of-function mutations of NCC cause renal salt wasting with arterial hypotension (Gitelman syndrome). Conversely, mutations in the NCC-regulating WNK kinases or kelch-like 3 protein cause familial hyperkalemic hypertension. Here, we performed automated sorting of mouse DCTs and microarray analysis for comprehensive identification of novel DCT-enriched gene products, which may potentially regulate DCT and NCC function. This approach identified protein phosphatase 1 inhibitor-1 (I-1) as a DCT-enriched transcript, and immunohistochemistry revealed I-1 expression in mouse and human DCTs and thick ascending limbs. In heterologous expression systems, coexpression of NCC with I-1 increased thiazide-dependent Na(+) uptake, whereas RNAi-mediated knockdown of endogenous I-1 reduced NCC phosphorylation. Likewise, levels of phosphorylated NCC decreased by approximately 50% in I-1 (I-1(-/-)) knockout mice without changes in total NCC expression. The abundance and phosphorylation of other renal sodium-transporting proteins, including NaPi-IIa, NKCC2, and ENaC, did not change, although the abundance of pendrin increased in these mice. The abundance, phosphorylation, and subcellular localization of SPAK were similar in wild-type (WT) and I-1(-/-) mice. Compared with WT mice, I-1(-/-) mice exhibited significantly lower arterial BP but did not display other metabolic features of NCC dysregulation. Thus, I-1 is a DCT-enriched gene product that controls arterial BP, possibly through regulation of NCC activity.

Indexed as

AnimalsAnion Transport ProteinsBlood PressureFemaleHumansHypotensionKidney Tubules, DistalLoop of HenleMaleMiceMice, TransgenicPhosphorylationProteinsProtein Serine-Threonine KinasesSolute Carrier Family 12, Member 1Solute Carrier Family 12, Member 3Anion Transport Proteinsphosphoprotein phosphatase inhibitor 1ProteinsProtein Serine-Threonine KinasesSlc26a4 protein, mouseSolute Carrier Family 12, Member 1Solute Carrier Family 12, Member 3Stk39 protein, mouseSulfate Transporters

Identifiers

PMID24231659
PMCPMC3935578
OpenAlexW2104757756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.